Scotia Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.1M | Sell |
127,501
-15,431
| -11% | -$2.03M | 0.06% | 174 |
|
|
2026
Q1 | $19.9M | Buy |
142,932
+11,247
| +9% | +$1.57M | 0.08% | 137 |
|
|
2025
Q4 | $16.2M | Buy |
131,685
+4,284
| +3% | +$521K | 0.07% | 160 |
|
|
2025
Q3 | $14.1M | Sell |
127,401
-7,667
| -6% | -$871K | 0.06% | 170 |
|
|
2025
Q2 | $15M | Sell |
135,068
-17,090
| -11% | -$1.82M | 0.07% | 157 |
|
|
2025
Q1 | $17M | Sell |
152,158
-10,591
| -7% | -$1.09M | 0.09% | 132 |
|
|
2024
Q4 | $15M | Buy |
162,749
+14,125
| +10% | +$1.27M | 0.08% | 139 |
|
|
2024
Q3 | $12.5M | Sell |
148,624
-1,568
| -1% | -$120K | 0.07% | 155 |
|
|
2024
Q2 | $10.3M | Sell |
150,192
-39,741
| -21% | -$2.65M | 0.06% | 166 |
|
|
2024
Q1 | $13.9M | Sell |
189,933
-5,429
| -3% | -$417K | 0.08% | 140 |
|
|
2023
Q4 | $15.8M | Buy |
195,362
+2,231
| +1% | +$174K | 0.1% | 121 |
|
|
2023
Q3 | $14.5M | Sell |
193,131
-1,495
| -0.8% | -$115K | 0.1% | 123 |
|
|
2023
Q2 | $15M | Sell |
194,626
-12,459
| -6% | -$994K | 0.1% | 123 |
|
|
2023
Q1 | $17.2M | Buy |
207,085
+24,705
| +14% | +$2.05M | 0.13% | 113 |
|
|
2022
Q4 | $15.7M | Sell |
182,380
-44,014
| -19% | -$3.49M | 0.12% | 113 |
|
|
2022
Q3 | $14M | Buy |
226,394
+42,724
| +23% | +$2.69M | 0.11% | 115 |
|
|
2022
Q2 | $11.4M | Sell |
183,670
-1,191
| -0.6% | -$73.7K | 0.08% | 144 |
|
|
2022
Q1 | $11M | Buy |
184,861
+48,592
| +36% | +$3.11M | 0.07% | 160 |
|
|
2021
Q4 | $9.89M | Sell |
136,269
-2,635
| -2% | -$181K | 0.06% | 172 |
|
|
2021
Q3 | $9.7M | Buy |
138,904
+3,843
| +3% | +$270K | 0.07% | 159 |
|
|
2021
Q2 | $9.3M | Sell |
135,061
-320
| -0.2% | -$21.4K | 0.07% | 170 |
|
|
2021
Q1 | $8.75M | Buy |
135,381
+77,708
| +135% | +$5.01M | 0.07% | 162 |
|
|
2020
Q4 | $3.36M | Sell |
57,673
-74,199
| -56% | -$4.48M | 0.03% | 268 |
|
|
2020
Q3 | $8.33M | Buy |
131,872
+1,766
| +1% | +$122K | 0.09% | 141 |
|
|
2020
Q2 | $10M | Buy |
130,106
+22,993
| +21% | +$1.76M | 0.14% | 105 |
|
|
2020
Q1 | $8.01M | Buy |
107,113
+33,719
| +46% | +$2.33M | 0.11% | 111 |
|
|
2019
Q4 | $4.77M | Sell |
73,394
-9,663
| -12% | -$629K | 0.05% | 178 |
|
|
2019
Q3 | $5.26M | Sell |
83,057
-40,920
| -33% | -$2.67M | 0.06% | 159 |
|
|
2019
Q2 | $8.38M | Buy |
123,977
+1,541
| +1% | +$101K | 0.1% | 122 |
|
|
2019
Q1 | $7.96M | Sell |
122,436
-3,429
| -3% | -$228K | 0.1% | 127 |
|
|
2018
Q4 | $7.87M | Sell |
125,865
-43,562
| -26% | -$3.04M | 0.12% | 113 |
|
|
2018
Q3 | $13.1M | Sell |
169,427
-25,229
| -13% | -$1.91M | 0.17% | 88 |
|
|
2018
Q2 | $14.6M | Buy |
194,656
+5,660
| +3% | +$400K | 0.2% | 83 |
|
|
2018
Q1 | $14.2M | Buy |
188,996
+18,792
| +11% | +$1.49M | 0.2% | 84 |
|
|
2017
Q4 | $12.2M | Buy |
170,204
+1,910
| +1% | +$145K | 0.16% | 94 |
|
|
2017
Q3 | $13.6M | Buy |
168,294
+21,883
| +15% | +$1.67M | 0.19% | 78 |
|
|
2017
Q2 | $10.4M | Buy |
146,411
+13,078
| +10% | +$870K | 0.17% | 91 |
|
|
2017
Q1 | $9.06M | Sell |
133,333
-15,679
| -11% | -$1.1M | 0.15% | 99 |
|
|
2016
Q4 | $10.7M | Sell |
149,012
-28,790
| -16% | -$2.14M | 0.17% | 96 |
|
|
2016
Q3 | $14M | Sell |
177,802
-44,678
| -20% | -$3.63M | 0.26% | 74 |
|
|
2016
Q2 | $18.6M | Sell |
222,480
-18,331
| -8% | -$1.63M | 0.38% | 57 |
|
|
2016
Q1 | $22.1M | Buy |
240,811
+23,056
| +11% | +$2.08M | 0.48% | 49 |
|
|
2015
Q4 | $21.1M | Hold |
217,755
| – | – | 0.48% | 44 |
|
|
2015
Q3 | $21.4M | Buy |
217,755
+16,501
| +8% | +$1.83M | 0.48% | 40 |
|
|
2015
Q2 | $23.2M | Buy |
201,254
+32,666
| +19% | +$3.57M | 0.47% | 39 |
|
|
2015
Q1 | $16.5M | Sell |
168,588
-1,342
| -0.8% | -$136K | 0.43% | 49 |
|
|
2014
Q4 | $16M | Buy |
169,930
+33,960
| +25% | +$3.51M | 0.42% | 50 |
|
|
2014
Q3 | $14.5M | Buy |
135,970
+10,362
| +8% | +$1.01M | 0.31% | 57 |
|
|
2014
Q2 | $10.4M | Buy |
125,608
+54,818
| +77% | +$4.27M | 0.23% | 73 |
|
|
2014
Q1 | $5.02M | Buy |
70,790
+758
| +1% | +$59.4K | 0.11% | 113 |
|
|
2013
Q4 | $5.26M | Buy |
70,032
+49,012
| +233% | +$3.41M | 0.13% | 105 |
|
|
2013
Q3 | $1.32M | Sell |
21,020
-90,380
| -81% | -$5.4M | 0.04% | 229 |
|
|
2013
Q2 | $5.71M | Buy |
+111,400
| New | +$5.81M | 0.22% | 73 |
|
Other funds holding GILD
Scotia Capital's GILD Position: Q2 2026 in Review
Scotia Capital reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $2.03M and leaving 127,501 shares worth $16.1M. The position accounts for 0.06% of the portfolio, ranked #174.
Scotia Capital first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.2M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Scotia Capital held 127,501 shares of Gilead Sciences worth $16.1M as of Q2 2026.
- Scotia Capital sold 15,431 Gilead Sciences shares in Q2 2026, an estimated $2.03M.
- Gilead Sciences made up 0.06% of Scotia Capital's portfolio in Q2 2026, its #174 holding.
- Scotia Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Scotia Capital's Gilead Sciences position peaked at $23.2M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.